LPL Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
LPL Financial's VRTX Position: Q2 2026 in Review
LPL Financial increased its Vertex Pharmaceuticals (VRTX) stake by 7.9% in Q2 2026, buying an estimated $9.33M and bringing the position to 289,111 shares worth $144M. The position accounts for 0.03% of the portfolio, ranked #503.
LPL Financial first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- LPL Financial held 289,111 shares of Vertex Pharmaceuticals worth $144M as of Q2 2026.
- LPL Financial bought 21,049 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.33M.
- Vertex Pharmaceuticals made up 0.03% of LPL Financial's portfolio in Q2 2026, its #503 holding.
- LPL Financial first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.